Moody Aldrich Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-30,930	Closed	-$509K	–	98
2017 Q2	$509K	Buy	30,930 +8,475	+38%	+$139K	0.63%	76
2017 Q1	$322K	Sell	22,455 -44,135	-66%	-$633K	0.55%	77
2016 Q4	$921K	Buy	66,590 +24,410	+58%	+$338K	0.59%	71
2016 Q3	$762K	Buy	+42,180	New	+$762K	0.53%	80